Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Links 'n Things -- Ignore unavailable to you. Want to Upgrade?

To: Elmer Flugum who wrote (320)	2/11/2005 12:07:35 AM
From: HG	Respond to of 536

Human Cloning License Granted to Dolly Creator By Thomas Wagner Associated Press posted: 08 February 2005 02:13 pm ET LONDON - The scientist who attracted the world's attention by cloning Dolly the Sheep is about to take another major step for medical research: cloning human embryos and extracting stem cells to unravel the mysteries of muscle-wasting illnesses like Lou Gehrig's disease. Ian Wilmut, who led the team that created Dolly at Scotland's Roslin Institute in 1996, was granted a cloning license Tuesday by British regulators to study how nerve cells go awry to cause motor neuron diseases. The experiments do not involve creating cloned babies, but the license has nonetheless stirred fresh controversy over the issue and prompted abortion foes and other biological conservatives to condemn the decision. "Are we supposed to be appeased by Professor Wilmut's declarations that the human embryos will be destroyed after experimentation and that his team has no intention of producing cloned babies?" asked Julia Millington of the London-based ProLife Alliance. "All human cloning is intrinsically wrong and should be outlawed. However, the creation of cloned human embryos destined for experimentation and subsequent destruction is particularly abhorrent." Wilmut, speaking after the announcement in Edinburgh, Scotland, defended the move. "We all take for granted the very much healthier life that we have now compared with people 100 years ago," he said. "I think that the majority of people support this type of research and hope it will be successful in helping to bring useful treatment for diseases like motor neuron disease." The license is the second one approved since Britain became the first country to legalize research cloning in 2001. The first was granted in August to a team that hopes to use cloning to create insulin-producing cells for transplant into diabetics. In the latest project, Wilmut and motor neuron expert Christopher Shaw of the Institute of Psychiatry in London plan to clone cells from patients with the disease, derive stem cells from the resulting embryo, make them develop into nerve cells and compare their evolution to that of cells derived from healthy embryos. The cloning technique, called cell nuclear replacement, is the same as that used to create Dolly. It has already been applied to humans by scientists in South Korea, who created the clone to extract stem cells. Dr. Brian Dickie, director of research at the London-based Motor Neuron Disease Association, said the experiments could revolutionize the future treatment of motor neuron disease, which afflicts about 350,000 people worldwide and kills about 100,000 people a year. "It's about 135 years since (motor neuron disease) was first characterized and here we are, more than a century later, and we still don't know the cause of over 95 percent of cases. We haven't got a diagnostic test for the disease and we've made very modest inroads in slowing the disease progression," Dickie said. "This opens up opportunities on three fronts: to understand how motor neurons become sick and die, to identify genetic causes of the disease and to rapidly screen new drugs," he said. The mechanism behind motor neuron disease is poorly understood because the nerves are inaccessible in the brain and central nervous system and can only be examined after the patient dies. Motor neuron disease is an umbrella term for a collection of illnesses of varying severity that all lead to loss of muscle function because of nerve failure. The most common is amyotrophic lateral sclerosis, also known as ALS or Lou Gehrig's disease. About 10 percent of those stricken live for a decade or more, like celebrated physicist Stephen Hawking. However, most die within five years of the onset of symptoms. Drugs prolong life by three to six months. An inherited defect in a single gene is responsible for about 2 percent of cases of the disease. Another 8 percent are caused by some other unidentified genetic abnormality. Stem cells are the master cells of the body, appearing when embryos are just a few days old and developing into every type of cell and tissue in the body. Scientists hope to be able to extract the stem cells from embryos when they are in their blank state and direct them to form any desired cell type to treat diseases ranging from Parkinson's to diabetes. Combining cloning with stem cell research will ensure the development of the right kind of cells for study, allowing scientists to see at which exact point things start to go wrong. The status of cloning varies widely across the world, and most countries have no laws or regulation in place. In the United States, federal government money cannot be used for cloning projects, but there are no restrictions on privately funded research. The United Nations is deadlocked over the issue and is scheduled to take it up later this month. The United States and Costa Rica are leading a bid to ban all forms of cloning, while Belgium is heading a faction that wants to allow it. Associated Press Medical Writer Emma Ross contributed to this report from Rome. Dolly, right, the first cloned sheep produced through nuclear transfer from differentiated adult sheep cells, and Polly, the world's first transgenic lamb, are in their pen at the Roslin Institute in Edinburgh, Scotland, in early December, 1997. Scientists at the Roslin Institute produced Molly and Polly cloned with a human gene so that their milk will contain a blood clotting protein that can be extracted for use in treating human hemophilia. Ian Wilmut's technique motivated many governments to ban research on human cloning. Dolly was later naturally mated and gave birth to a healthy lamb. (AP Photo/John Chadwick)

To: Elmer Flugum who wrote (320)	7/29/2005 2:43:03 PM
From: HG	Respond to of 536

This one is kinda cool : thoseshirts.com The whole enchilada thoseshirts.com

To: Elmer Flugum who wrote (320)	10/4/2006 8:44:37 PM
From: HG	Read Replies (2) \| Respond to of 536

He's bitter and twisted He knows what he wants He wants to be loved and he wants to belong He wants us to listen, he wants us to weep And he was a stupid baby who turned into a powerful freak But how do you? How do you? How do you? He lives with his mother But we show him respect He's a dangerous bigot, but we always forget And he's just like his daddy because he cheats on his friends And he steals and he bullies anyway that he can But how do you? How do you? How do you? -Radiohead